Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Gynecologic Oncology Physician in Birmingham, AL
NPI: 1255313193Primary Employer
University of Alabama Health Services Foundation, PC.
uabmedicine.org
HQ Phone
Get Charles's Phone NumberMobile
Get Charles's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAL State Medical License
SD State Medical License
2027
MS State Medical License
2017 - 2026
AL State Medical License
1999 - 2025
TX State Medical License
2006 - 2024
American Board of Obstetrics and Gynecology
Obstetrics & Gynecology
American Board of Obstetrics and Gynecology
Gynecologic Oncology
University of Alabama at Birmingham School of Public Health
Masters • Clinical and Translational Sciences
2012 - 2014
Medical University of South Carolina (MUSC)
medicine.musc.edu
Medical School
Until 1998
Citadel
BS • Biological Sciences
1990 - 1994
University of Alabama Medical Center
Residency • Obstetrics and Gynecology
1998 - 2002
Fellowship • Gynecologic Oncology
2002 - 2005
University of South Carolina
No Degree • 1992 - 1993
1992 - 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 61 | 134 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 58 | 68 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 43 | 47 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 14 | 14 |
Authors: Britt Erickson, Laura Daily, Warner Huh, John Straughn
Journal: J Low Genit Tract Dis
Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer.
Authors: Laura Havrilesky, Rex Bentley, Warner Huh
Journal: Gynecol Oncol
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, RADIATION: External Beam Radiation Therapy, DRUG: Cisplatin, RADIATION: Radiation Therapy, RADIATION: Intensity-Modulated Radiation Therapy, DRUG: Triapine, RADIATION: Brachytherapy
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: AstraZeneca, NRG Oncology
Intervention / Treatment: DRUG: Carboplatin, PROCEDURE: Magnetic Resonance Imaging, OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, PROCEDURE: Biospecimen Collection, DRUG: Gemcitabine Hydrochloride, DRUG: Olaparib, OTHER: Quality-of-Life Assessment, DRUG: Gemcitabine, DRUG: Paclitaxel, PROCEDURE: Computed Tomography, PROCEDURE: Multigated Acquisition Scan, DRUG: Pegylated Liposomal Doxorubicin Hydrochloride, PROCEDURE: Echocardiography Test, DRUG: Cediranib Maleate
Lead Sponsor: University of Alabama at Birmingham
Collaborators: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: LDE225